CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing application areas of protein assays
4.1.2. Decreasing sequencing costs
4.1.3. Increasing pharmaceutical and biotech R&D expenditure
4.1.4. Favourable government funding scenario for proteomics research
4.2. Market Restraints & Challenges
4.2.1. The dearth of trained professionals
4.2.2. The high cost of multiplex assay equipment
4.3. Market Opportunities
4.3.1. Biomarker identification
4.3.2. Emerging economies
CHAPTER 5 GLOBAL PROTEIN ASSAYS MARKET – BY PRODUCT
5.1. Introduction
5.2. Kits
5.3. Reagents
5.4. Instruments and Accessories
CHAPTER 6 GLOBAL PROTEIN ASSAYS MARKET – BY TYPE
6.1. Introduction
6.2. Dye-binding assays
6.3. Test strip-based assays
6.4. Copper-ion-based assays
6.5. Other protein assays
CHAPTER 7 GLOBAL PROTEIN ASSAYS MARKET - BY TECHNOLOGY
7.1. Introduction
7.2. Fluorescence-based protein assays
7.3. Colorimetric protein assays
7.4. Absorbance-based protein assays
CHAPTER 8 GLOBAL PROTEIN ASSAYS MARKET - BY APPLICATION
8.1. Introduction
8.2. Disease diagnosis
8.3. Drug discovery & development
8.4. Other applications
CHAPTER 9 GLOBAL PROTEIN ASSAYS MARKET - BY END USER
9.1. Introduction
9.2. Academic research institutes
9.3. Hospitals
9.4. Clinical laboratories
9.5. Pharmaceutical and biotechnology companies
9.6. Other end users
CHAPTER 10 GLOBAL PROTEIN ASSAYS MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. Asia Pacific
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL PROTEIN ASSAYS MARKET - COMPANY PROFILES
11.1. GE Healthcare.
11.2. Thermo Fisher Scientific
11.3. Qiagen N.V.
11.4. Bio-Rad Laboratories.
11.5. Illumina, Inc.
11.6. Abcam.
11.7. Becton, Dickinson and Company.
11.8. PerkinElmer Inc.
11.9. Cell Signaling Technology, Inc.
11.10. SEEGENE INC.
11.11. Myriad Genetics Inc.
11.12. Luminex Corporation.
11.13. Danaher Corporation.
11.14. MESO SCALE DIAGNOSTICS, LLC.
11.15. RANDOX LABORATORIES LTD.
CHAPTER 12 GLOBAL PROTEIN ASSAYS MARKET - COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
